| Pregnancy |
1 |
1 |
| Heart Failure (HF) |
0 |
0.7 |
| Postpartum |
0 |
0.57 |
| Congenital Anomaly |
0 |
0.41 |
| Birth |
0 |
0.36 |
| Preeclampsia |
0 |
0.35 |
| Coronary Artery Disease (CAD) |
0 |
0.33 |
| Premature Birth |
0 |
0.33 |
| Antihypertensive Agents |
0 |
0.31 |
| Low Birth Weight |
0 |
0.29 |
| Asthma |
0 |
0.28 |
| Cardiovascular disease |
0 |
0.21 |
| Hospital |
0 |
0.21 |
| Newborn |
0 |
0.21 |
| Cardiovascular Risk Management |
0 |
0.15 |
| Epidemic |
0 |
0.15 |
| Heart |
0 |
0.15 |
| Depression |
0 |
0.14 |
| Blood Transfusion |
0 |
0.12 |
| Angiotensin II Receptor Blockade |
0 |
0.11 |
| Cerebrovascular Accident |
0 |
0.11 |
| Acute Kidney Injury |
0 |
0.1 |
| Blood |
0 |
0.1 |
| Calcium |
0 |
0.1 |
| Hypotension |
0 |
0.1 |
| Patient History |
0 |
0.1 |
| Receptors |
0 |
0.1 |
| Thromboembolism |
0 |
0.1 |
| Centers for Disease Control and Prevention |
0 |
0.09 |
| Disseminated Intravascular Coagulation |
0 |
0.07 |
| Patient Safety |
0 |
0.07 |
| Pulmonary Edema |
0 |
0.07 |
| Renal Failure |
0 |
0.06 |
| ACE Inhibitor |
0 |
0.05 |
| Adverse Effects |
0 |
0.05 |
| Artery |
0 |
0.05 |
| Body Mass Index |
0 |
0.05 |
| Breastfeeding |
0 |
0.05 |
| Bronchospasm |
0 |
0.05 |
| Central Nervous System |
0 |
0.05 |
| Coagulation |
0 |
0.05 |
| Diet |
0 |
0.05 |
| Dizziness |
0 |
0.05 |
| Eclampsia |
0 |
0.05 |
| Edema |
0 |
0.05 |
| Fetal Growth Restriction |
0 |
0.05 |
| Gestational Age |
0 |
0.05 |
| Injury |
0 |
0.05 |
| Inpatient Care |
0 |
0.05 |
| Kidney |
0 |
0.05 |
| Maternal Mortality |
0 |
0.05 |
| Meta-Analysis |
0 |
0.05 |
| Poverty |
0 |
0.05 |
| Proteinuria |
0 |
0.05 |
| Racism |
0 |
0.05 |
| Shock |
0 |
0.05 |
| Stillbirth |
0 |
0.05 |
| Transfusion |
0 |
0.05 |
| Tyrosine Kinase |
0 |
0.05 |
| Obesity |
0 |
0.04 |
| Osteoarthritis |
0 |
0.04 |
| Social Determinants of Health |
0 |
0.04 |
| Medical Life |
0 |
0.03 |
| Peripheral Artery Disease |
0 |
0.02 |
| Sepsis |
0 |
0.02 |
| Type 2 Diabetes Mellitus |
0 |
0.02 |
| Wound Management |
0 |
0.02 |